StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ENZN

Viskase Holdings Inc

ENZN OTC Biological Products, (No Diagnostic Substances) EDGAR ↗
$4.71
+0.06 +1.29%

Key statistics

from XBRL data in SEC filings
Market cap
$67.5M
Revenue (TTM)
$26.0K
Net income (TTM)
$18.7M
EPS (TTM)
$5.13
P/E ratio
0.9
Dividend yield
Free cash flow
Cash
$7.91M
Total assets
$424M
Gross margin
52-week range
$4.00 – $33.80

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure May 5, 2026 10-Q Quarter ended 2026-03-31 May 4, 2026 8-K/A FORM 8-K/A May 1, 2026 8-K Director or officer change May 1, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 29, 2026 8-K Entered a material agreement; Took on a direct financial obligation Apr 21, 2026 8-K Changed accountants Apr 16, 2026 8-K Director or officer change Apr 15, 2026 8-K Completed an acquisition or disposition; Unregistered sale of equity; Change in control; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Mar 26, 2026 8-K Regulation FD disclosure Mar 25, 2026 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Mar 24, 2026 8-K Regulation FD disclosure Mar 19, 2026 8-K Entered a material agreement; Modified rights of security holders Mar 18, 2026 8-K Regulation FD disclosure Mar 16, 2026 8-K Entered a material agreement; Modified rights of security holders; Regulation FD disclosure Mar 11, 2026 8-K Regulation FD disclosure Mar 9, 2026 10-K Fiscal year ended 2025-12-31 Mar 2, 2026 8-K Entered a material agreement; Modified rights of security holders; Regulation FD disclosure Feb 27, 2026 8-K Shareholder vote results Feb 11, 2026 8-K Entered a material agreement; Modified rights of security holders Jan 30, 2026 8-K Entered a material agreement; Modified rights of security holders Dec 23, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Entered a material agreement; Regulation FD disclosure Oct 24, 2025 8-K Entered a material agreement; Modified rights of security holders Sep 30, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Entered a material agreement; Regulation FD disclosure Jun 23, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 28, 2025 8-K Entered a material agreement; Modified rights of security holders Apr 1, 2025 10-K Fiscal year ended 2024-12-31 Feb 21, 2025 8-K Director or officer change; Other events Jan 10, 2025 8-K Other events Dec 27, 2024 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Shareholder vote results Oct 1, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K/A Item 5.08 Jul 11, 2024 8-K Item 5.08 Jul 2, 2024 8-K Other events Jun 14, 2024 8-K Entered a material agreement; Modified rights of security holders May 22, 2024